# OFS Capital Corp: financial statements, quarterly

OFS · Nasdaq · CIK 1487918 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ofs.md) · [Financials](/companies/ofs/financials.md) · [Filings](/companies/ofs/filings.md) · [Insiders](/companies/ofs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ofs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [4.9](/filings/0001487918-24-000081.md) | [4.7 d](/filings/0001487918-26-000021.md) | [4.6](/filings/0001487918-25-000035.md) | [4.1](/filings/0001487918-25-000093.md) | [4.0](/filings/0001487918-25-000108.md) | [3.9 d](/filings/0001487918-26-000021.md) | [3.9](/filings/0001487918-26-000054.md) | [3.8](/filings/0001487918-26-000078.md) | [4.5](/filings/0001487918-25-000108.md) | [4.3 d](/filings/0001487918-26-000021.md) | [3.9](/filings/0001487918-26-000054.md) | [3.7](/filings/0001487918-26-000078.md) |
| Net income | $m | [1.8](/filings/0001487918-24-000081.md) | [(4.1) d](/filings/0001487918-26-000021.md) | [(9.0)](/filings/0001487918-25-000035.md) | [10.3](/filings/0001487918-25-000093.md) | [1.7](/filings/0001487918-25-000108.md) | [25.5 d](/filings/0001487918-26-000021.md) | [(7.3)](/filings/0001487918-26-000054.md) | [(9.6)](/filings/0001487918-26-000078.md) | [(5.3)](/filings/0001487918-25-000108.md) | [(10.8) d](/filings/0001487918-26-000021.md) | [(11.6)](/filings/0001487918-26-000054.md) | [5.6](/filings/0001487918-26-000078.md) |
| Diluted EPS | $ per share | [0.40](/filings/0001487918-24-000081.md) | not reported | [0.42](/filings/0001487918-25-000035.md) | [0.26](/filings/0001487918-25-000093.md) | [0.27](/filings/0001487918-25-000108.md) | not reported | [(0.54)](/filings/0001487918-26-000054.md) | [(0.72)](/filings/0001487918-26-000078.md) | [0.22](/filings/0001487918-25-000108.md) | not reported | [(0.86)](/filings/0001487918-26-000054.md) | [0.42](/filings/0001487918-26-000078.md) |
| Basic EPS | $ per share | [0.40](/filings/0001487918-24-000081.md) | not reported | [0.42](/filings/0001487918-25-000035.md) | [0.26](/filings/0001487918-25-000093.md) | [0.27](/filings/0001487918-25-000108.md) | not reported | [(0.54)](/filings/0001487918-26-000054.md) | [(0.72)](/filings/0001487918-26-000078.md) | [0.22](/filings/0001487918-25-000108.md) | not reported | [(0.86)](/filings/0001487918-26-000054.md) | [0.42](/filings/0001487918-26-000078.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [15.9](/filings/0001487918-23-000101.md) | [45.3](/filings/0001487918-25-000009.md) | [6.1](/filings/0001487918-24-000043.md) | [5.6](/filings/0001487918-24-000076.md) | [20.3](/filings/0001487918-24-000081.md) | [6.1](/filings/0001487918-26-000021.md) | [4.1](/filings/0001487918-25-000035.md) | [10.2](/filings/0001487918-25-000093.md) | [5.0](/filings/0001487918-25-000108.md) | [3.4](/filings/0001487918-26-000078.md) | [3.3](/filings/0001487918-26-000054.md) | [4.0](/filings/0001487918-26-000078.md) |
| Total assets | $m | [477](/filings/0001487918-23-000101.md) | [470](/filings/0001487918-25-000009.md) | [410](/filings/0001487918-24-000043.md) | [408](/filings/0001487918-24-000076.md) | [419](/filings/0001487918-24-000081.md) | [428](/filings/0001487918-26-000021.md) | [412](/filings/0001487918-25-000035.md) | [395](/filings/0001487918-25-000093.md) | [378](/filings/0001487918-25-000108.md) | [347](/filings/0001487918-26-000078.md) | [316](/filings/0001487918-26-000054.md) | [304](/filings/0001487918-26-000078.md) |
| Total liabilities | $m | [306](/filings/0001487918-23-000101.md) | [308](/filings/0001487918-25-000009.md) | [262](/filings/0001487918-24-000043.md) | [254](/filings/0001487918-24-000076.md) | [267](/filings/0001487918-24-000081.md) | [256](/filings/0001487918-26-000021.md) | [252](/filings/0001487918-25-000035.md) | [249](/filings/0001487918-25-000093.md) | [242](/filings/0001487918-25-000108.md) | [224](/filings/0001487918-26-000078.md) | [206](/filings/0001487918-26-000054.md) | [192](/filings/0001487918-26-000078.md) |
| Long-term debt | $m | [303](/filings/0001487918-23-000101.md) | not reported | [259](/filings/0001487918-24-000043.md) | [249](/filings/0001487918-24-000076.md) | [249](/filings/0001487918-24-000081.md) | not reported | [248](/filings/0001487918-25-000035.md) | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [171](/filings/0001487918-24-000081.md) | [162](/filings/0001487918-26-000021.md) | [148](/filings/0001487918-25-000093.md) | [154](/filings/0001487918-25-000108.md) | [151](/filings/0001487918-25-000108.md) | [172](/filings/0001487918-26-000078.md) | [160](/filings/0001487918-26-000078.md) | [146](/filings/0001487918-26-000078.md) | [136](/filings/0001487918-25-000108.md) | [123](/filings/0001487918-26-000078.md) | [109](/filings/0001487918-26-000078.md) | [113](/filings/0001487918-26-000078.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [38.2 d](/filings/0001487918-24-000081.md) | [34.6 d](/filings/0001487918-26-000021.md) | [9.2](/filings/0001487918-25-000035.md) | [13.4 d](/filings/0001487918-25-000093.md) | [19.3 d](/filings/0001487918-25-000108.md) | [(8.9) d](/filings/0001487918-26-000021.md) | [2.8](/filings/0001487918-26-000054.md) | [15.4 d](/filings/0001487918-26-000078.md) | [6.0 d](/filings/0001487918-25-000108.md) | [19.4 d](/filings/0001487918-26-000021.md) | [21.8](/filings/0001487918-26-000054.md) | [17.4 d](/filings/0001487918-26-000078.md) |
| Dividends paid | $m | [4.6](/filings/0001487918-24-000081.md) | [4.6 d](/filings/0001487918-26-000021.md) | [4.6](/filings/0001487918-25-000035.md) | [4.6](/filings/0001487918-24-000081.md) | [4.6](/filings/0001487918-24-000081.md) | [4.6 d](/filings/0001487918-26-000021.md) | [4.6](/filings/0001487918-26-000054.md) | [4.6 d](/filings/0001487918-26-000078.md) | [4.6 d](/filings/0001487918-25-000108.md) | [2.3 d](/filings/0001487918-26-000021.md) | [2.3](/filings/0001487918-26-000054.md) | [0.0 d](/filings/0001487918-26-000078.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.4](/filings/0001487918-23-000101.md) | [13.4](/filings/0001487918-24-000043.md) | [13.4](/filings/0001487918-24-000076.md) | [13.4](/filings/0001487918-24-000081.md) | [13.4](/filings/0001487918-25-000035.md) | [13.4](/filings/0001487918-25-000093.md) | [13.4](/filings/0001487918-25-000108.md) | [13.4](/filings/0001487918-26-000054.md) | [13.4](/filings/0001487918-26-000078.md) | [13.4](/filings/0001487918-25-000108.md) | [13.4](/filings/0001487918-26-000054.md) | [13.4](/filings/0001487918-26-000078.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 13,398,078 at 2026-07-27, from the cover of the [10-Q filed 2026-07-31](/filings/0001487918-26-000078.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.